THU0159 Barriers to Rheumatoid Arthritis Treatment Optimisation: Real-World Data From the Arthritispower Registry

doi 10.1136/annrheumdis-2018-eular.2314
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Treatment of Patients With Rheumatoid Arthritis: Real World Population-Based Evidence From France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Antiplatelet Treatment in Acute Coronary Syndrome Patients: Real-World Data From the START-Antiplatelet Italian Registry

PLoS ONE
Multidisciplinary
2019English

AB0432 Biologic Dmards Treatment Retention in Patients With Rheumatoid Arthritis According to the Moscow Arthritis Registry (MERA)

2018English

Planning of a Clinical Data Registry for Basic Anti-Inflammatory Drugs for the Treatment of Rheumatoid Arthritis

The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products
2018English

Correction To: Switching From Natalizumab to Fingolimod Treatment in Multiple Sclerosis: Real Life Data From the Austrian MS Treatment Registry

Journal of Neurology
Neurology
2019English

Outcomes of Disease Activity in Rheumatoid Arthritis and Health Insurance: Results From Real World

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real‐World Data From the Spanish Tumor Registry (R‐GETNE)

Oncologist
Cancer ResearchMedicineOncology
2018English

SAT0211 Real World Data of Rituximab Effectiveness in Rheumatoid Arthritis: Differences Between Biologic-Naive Patients and Previously Exposed to Biologics

2017English

Incidence of Gastrointestinal Perforations in Patients With Rheumatoid Arthritis Treated With Tocilizumab From Clinical Trial, Postmarketing, and Real-World Data Sources

Rheumatology and Therapy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy